APO RESEARCH · REPORT
Msenchymal Stem Cell and Exosome Diagnostics and Therapies
Selected research
Industry Research
Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Research Report 2026
Market perspective
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Msenchymal Stem Cell and Exosome Diagnostics and Therapies market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Msenchymal Stem Cell and Exosome Diagnostics and Therapies market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Msenchymal Stem Cell and Exosome Diagnostics and Therapies market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Asian Institute of Gastroenterology, Cellular Biomedicine Group, Tianjin Angsai Cell Genetic Engineering Co.Ltd, Shanghai Aisar Biotechnology Co. Ltd, Qingdao Aoke Biological Development Co.Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Guangzhou Celera Stem Cell Technology Co. Ltd., Bosheng Excellence Biotechnology (Beijing) Co. Ltd and Beijing Han's United Biotechnology Co. Ltd, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Msenchymal Stem Cell and Exosome Diagnostics and Therapies.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market by Company
Asian Institute of Gastroenterology
Cellular Biomedicine Group
Tianjin Angsai Cell Genetic Engineering Co.Ltd
Shanghai Aisar Biotechnology Co. Ltd
Qingdao Aoke Biological Development Co.Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Guangzhou Celera Stem Cell Technology Co. Ltd.
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Beijing Han's United Biotechnology Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Beijing SH biotechnology Co.Ltd
Stempeutics Research Pvt Ltd
Stem Med Pte Ltd
Cytopeutics Sdn Bhd
CryoCord Sdn Bhd
Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Type
Type I
Type II
Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Application
Skincare
Diagnostics
Therapies
Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Msenchymal Stem Cell and Exosome Diagnostics and Therapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Msenchymal Stem Cell and Exosome Diagnostics and Therapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2021-2026)
Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Type (2027-2032)
Table 9. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2021-2026)
Table 11. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Application (2027-2032)
Table 13. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2021-2026)
Table 16. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region (2027-2032)
Table 18. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends
Table 19. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Drivers
Table 20. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Opportunities and Challenges
Table 21. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints
Table 22. Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2021-2026)
Table 24. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies, Headquarters and Area Served
Table 26. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032) & (US$ Million)
Table 45. Asian Institute of Gastroenterology Company Information
Table 46. Asian Institute of Gastroenterology Business Overview
Table 47. Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 48. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 49. Asian Institute of Gastroenterology Recent Developments
Table 50. Cellular Biomedicine Group Company Information
Table 51. Cellular Biomedicine Group Business Overview
Table 52. Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 53. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 54. Cellular Biomedicine Group Recent Developments
Table 55. Tianjin Angsai Cell Genetic Engineering Co.Ltd Company Information
Table 56. Tianjin Angsai Cell Genetic Engineering Co.Ltd Business Overview
Table 57. Tianjin Angsai Cell Genetic Engineering Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 58. Tianjin Angsai Cell Genetic Engineering Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 59. Tianjin Angsai Cell Genetic Engineering Co.Ltd Recent Developments
Table 60. Shanghai Aisar Biotechnology Co. Ltd Company Information
Table 61. Shanghai Aisar Biotechnology Co. Ltd Business Overview
Table 62. Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 63. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 64. Shanghai Aisar Biotechnology Co. Ltd Recent Developments
Table 65. Qingdao Aoke Biological Development Co.Ltd Company Information
Table 66. Qingdao Aoke Biological Development Co.Ltd Business Overview
Table 67. Qingdao Aoke Biological Development Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 68. Qingdao Aoke Biological Development Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 69. Qingdao Aoke Biological Development Co.Ltd Recent Developments
Table 70. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Information
Table 71. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
Table 72. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 73. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 74. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Developments
Table 75. Guangzhou Celera Stem Cell Technology Co. Ltd. Company Information
Table 76. Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
Table 77. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 78. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 79. Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Developments
Table 80. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Information
Table 81. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
Table 82. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 83. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 84. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Developments
Table 85. Beijing Han's United Biotechnology Co. Ltd Company Information
Table 86. Beijing Han's United Biotechnology Co. Ltd Business Overview
Table 87. Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 88. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 89. Beijing Han's United Biotechnology Co. Ltd Recent Developments
Table 90. Beijing Beilai Biotechnology Co. Ltd Company Information
Table 91. Beijing Beilai Biotechnology Co. Ltd Business Overview
Table 92. Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 93. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 94. Beijing Beilai Biotechnology Co. Ltd Recent Developments
Table 95. Beijing SH biotechnology Co.Ltd Company Information
Table 96. Beijing SH biotechnology Co.Ltd Business Overview
Table 97. Beijing SH biotechnology Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 98. Beijing SH biotechnology Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 99. Beijing SH biotechnology Co.Ltd Recent Developments
Table 100. Stempeutics Research Pvt Ltd Company Information
Table 101. Stempeutics Research Pvt Ltd Business Overview
Table 102. Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 103. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 104. Stempeutics Research Pvt Ltd Recent Developments
Table 105. Stem Med Pte Ltd Company Information
Table 106. Stem Med Pte Ltd Business Overview
Table 107. Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 108. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 109. Stem Med Pte Ltd Recent Developments
Table 110. Cytopeutics Sdn Bhd Company Information
Table 111. Cytopeutics Sdn Bhd Business Overview
Table 112. Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 113. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 114. Cytopeutics Sdn Bhd Recent Developments
Table 115. CryoCord Sdn Bhd Company Information
Table 116. CryoCord Sdn Bhd Business Overview
Table 117. CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026) & (US$ Million)
Table 118. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
Table 119. CryoCord Sdn Bhd Recent Developments
Table 120. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Image
Figure 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Type: 2025 VS 2032
Figure 7. Type I Product
Figure 8. Type II Product
Figure 9. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Application: 2025 VS 2032
Figure 11. Skincare Product
Figure 12. Diagnostics Product
Figure 13. Therapies Product
Figure 14. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Region: 2025 VS 2032
Figure 17. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Players in 2025
Figure 18. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Manufacturers Established Date
Figure 19. Global Top 5 and 10 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players Market Share by Revenue in 2025
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 22. North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 23. United States Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 26. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 28. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Spain Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Netherlands Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 38. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 43. Australia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Taiwan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Country (2021-2032)
Figure 48. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Chile Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Colombia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Peru Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Asian Institute of Gastroenterology Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 54. Cellular Biomedicine Group Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 55. Tianjin Angsai Cell Genetic Engineering Co.Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 56. Shanghai Aisar Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 57. Qingdao Aoke Biological Development Co.Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 58. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 59. Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 60. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 61. Beijing Han's United Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 62. Beijing Beilai Biotechnology Co. Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 63. Beijing SH biotechnology Co.Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 64. Stempeutics Research Pvt Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 65. Stem Med Pte Ltd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 66. Cytopeutics Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Figure 67. CryoCord Sdn Bhd Revenue Growth Rate in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
Scope & coverage.
Types
- Type I
- Type II
Applications
- Skincare
- Diagnostics
- Therapies
Companies covered
- Asian Institute of Gastroenterology
- Cellular Biomedicine Group
- Tianjin Angsai Cell Genetic Engineering Co.Ltd
- Shanghai Aisar Biotechnology Co. Ltd
- Qingdao Aoke Biological Development Co.Ltd
- Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
- Guangzhou Celera Stem Cell Technology Co. Ltd.
- Bosheng Excellence Biotechnology (Beijing) Co. Ltd
- Beijing Han's United Biotechnology Co. Ltd
- Beijing Beilai Biotechnology Co. Ltd
- Beijing SH biotechnology Co.Ltd
- Stempeutics Research Pvt Ltd
- Stem Med Pte Ltd
- Cytopeutics Sdn Bhd
- CryoCord Sdn Bhd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Type I
- 2.2.3 Type II
- 2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Skincare
- 2.3.3 Diagnostics
- 2.3.4 Therapies
- 2.4 Assumptions and Limitations
3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Type
- 3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Type (2021-2026)
- 3.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2027-2032)
4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Application
- 4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Application (2021-2026)
- 4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Perspective (2021-2032)
- 5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Growth Trends by Region
- 5.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Region (2021-2026)
- 5.2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2027-2032)
- 5.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Dynamics
- 5.3.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends
- 5.3.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers
- 5.3.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges
- 5.3.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue
- 6.1.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (2021-2026)
- 6.1.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2021-2026)
- 6.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies Head Office and Area Served
- 6.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players, Product Type & Application
- 6.5 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Manufacturers Established Date
- 6.6 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021-2032)
- 7.2 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026)
- 7.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021-2032)
- 8.2 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026)
- 8.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021-2032)
- 9.2 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021-2032)
- 10.2 South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026)
- 10.4 South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2021-2032)
- 11.2 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Asian Institute of Gastroenterology
- 12.1.1 Asian Institute of Gastroenterology Company Information
- 12.1.2 Asian Institute of Gastroenterology Business Overview
- 12.1.3 Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.1.4 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.1.5 Asian Institute of Gastroenterology Recent Developments
- 12.2 Cellular Biomedicine Group
- 12.2.1 Cellular Biomedicine Group Company Information
- 12.2.2 Cellular Biomedicine Group Business Overview
- 12.2.3 Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.2.4 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.2.5 Cellular Biomedicine Group Recent Developments
- 12.3 Tianjin Angsai Cell Genetic Engineering Co.Ltd
- 12.3.1 Tianjin Angsai Cell Genetic Engineering Co.Ltd Company Information
- 12.3.2 Tianjin Angsai Cell Genetic Engineering Co.Ltd Business Overview
- 12.3.3 Tianjin Angsai Cell Genetic Engineering Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.3.4 Tianjin Angsai Cell Genetic Engineering Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.3.5 Tianjin Angsai Cell Genetic Engineering Co.Ltd Recent Developments
- 12.4 Shanghai Aisar Biotechnology Co. Ltd
- 12.4.1 Shanghai Aisar Biotechnology Co. Ltd Company Information
- 12.4.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
- 12.4.3 Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.4.4 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.4.5 Shanghai Aisar Biotechnology Co. Ltd Recent Developments
- 12.5 Qingdao Aoke Biological Development Co.Ltd
- 12.5.1 Qingdao Aoke Biological Development Co.Ltd Company Information
- 12.5.2 Qingdao Aoke Biological Development Co.Ltd Business Overview
- 12.5.3 Qingdao Aoke Biological Development Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.5.4 Qingdao Aoke Biological Development Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.5.5 Qingdao Aoke Biological Development Co.Ltd Recent Developments
- 12.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
- 12.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Information
- 12.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
- 12.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Developments
- 12.7 Guangzhou Celera Stem Cell Technology Co. Ltd.
- 12.7.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Information
- 12.7.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
- 12.7.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.7.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.7.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Developments
- 12.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
- 12.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Information
- 12.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
- 12.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Developments
- 12.9 Beijing Han's United Biotechnology Co. Ltd
- 12.9.1 Beijing Han's United Biotechnology Co. Ltd Company Information
- 12.9.2 Beijing Han's United Biotechnology Co. Ltd Business Overview
- 12.9.3 Beijing Han's United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.9.4 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.9.5 Beijing Han's United Biotechnology Co. Ltd Recent Developments
- 12.10 Beijing Beilai Biotechnology Co. Ltd
- 12.10.1 Beijing Beilai Biotechnology Co. Ltd Company Information
- 12.10.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
- 12.10.3 Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.10.4 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.10.5 Beijing Beilai Biotechnology Co. Ltd Recent Developments
- 12.11 Beijing SH biotechnology Co.Ltd
- 12.11.1 Beijing SH biotechnology Co.Ltd Company Information
- 12.11.2 Beijing SH biotechnology Co.Ltd Business Overview
- 12.11.3 Beijing SH biotechnology Co.Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.11.4 Beijing SH biotechnology Co.Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.11.5 Beijing SH biotechnology Co.Ltd Recent Developments
- 12.12 Stempeutics Research Pvt Ltd
- 12.12.1 Stempeutics Research Pvt Ltd Company Information
- 12.12.2 Stempeutics Research Pvt Ltd Business Overview
- 12.12.3 Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.12.4 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.12.5 Stempeutics Research Pvt Ltd Recent Developments
- 12.13 Stem Med Pte Ltd
- 12.13.1 Stem Med Pte Ltd Company Information
- 12.13.2 Stem Med Pte Ltd Business Overview
- 12.13.3 Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.13.4 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.13.5 Stem Med Pte Ltd Recent Developments
- 12.14 Cytopeutics Sdn Bhd
- 12.14.1 Cytopeutics Sdn Bhd Company Information
- 12.14.2 Cytopeutics Sdn Bhd Business Overview
- 12.14.3 Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.14.4 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.14.5 Cytopeutics Sdn Bhd Recent Developments
- 12.15 CryoCord Sdn Bhd
- 12.15.1 CryoCord Sdn Bhd Company Information
- 12.15.2 CryoCord Sdn Bhd Business Overview
- 12.15.3 CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2021-2026)
- 12.15.4 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Portfolio
- 12.15.5 CryoCord Sdn Bhd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst